The statement in the article that other manufacturers don't have the ability to manufacture the vaccine and that it would take 3 yrs to produce is wrong.
Teva had offered but was rejected & there are other facilities in India and S. Korea, that can do it but are not utilised.
production starts on average around 6 months after tech transfer. KEI's database of manufacturing capacity is v helpful, via @abinader
truly sorry to say but can't help but get an increasing impression that the vaccine monopoly holders & their beneficiary licensees are doing everything to keep away (generic) competitors from producing more vaccines and maintain artificial scarcity for profit. morally despicable
I can't believe how wrong the 3 yrs claim to vaccine production is, it's taken straight from pharma PR. There is a piece in the Intercept on idle global manufacturing capacity, which also confirms @DrTomFrieden's observation here:

• • •

Missing some Tweet in this thread? You can try to force a refresh

Keep Current with Hyo Yoon KANG 강효윤

Hyo Yoon KANG 강효윤 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!


Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @hyoyoonkang

1 May
Seeing lots of tweets today who dismiss TRIPS waiver initiative for good or bad reasons, none of them IP specialists. That's fine. But there has been LOTS of discussion pro&contra already.
from IP law point of view, the compulsory license requirements in TRIPS are onerous and not suitable for a pandemic emergency situation. TRIPS was designed for global pandemic but for global trade.
TRIPS waiver or compulsory license is not enough, yes you need tech transfer, but they go hand in hand bec tech transfer is dependent on the IP holder of patent or trade secret.
Read 9 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!